These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33185015)

  • 1. Prokinetic actions of luminally acting 5-HT
    Konen JR; Haag MM; Guseva D; Hurd M; Linton AA; Lavoie B; Kerrigan CB; Joyce E; Bischoff SC; Swann S; Griffin L; Matsukawa J; Falk MD; Gibson TS; Hennig GW; Wykosky J; Mawe GM
    Neurogastroenterol Motil; 2021 Apr; 33(4):e14026. PubMed ID: 33185015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luminal 5-HT
    Gwynne RM; Bornstein JC
    Neurogastroenterol Motil; 2019 Oct; 31(10):e13708. PubMed ID: 31524331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity.
    Hoffman JM; Tyler K; MacEachern SJ; Balemba OB; Johnson AC; Brooks EM; Zhao H; Swain GM; Moses PL; Galligan JJ; Sharkey KA; Greenwood-Van Meerveld B; Mawe GM
    Gastroenterology; 2012 Apr; 142(4):844-854.e4. PubMed ID: 22226658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel, potent and highly selective 5-HT
    Jeong EJ; Chung SY; Hong HN; Oh SW; Sim JY
    Br J Pharmacol; 2018 Feb; 175(3):485-500. PubMed ID: 29139561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colonic 5-HT
    Galligan JJ
    Neurogastroenterol Motil; 2021 Apr; 33(4):e14125. PubMed ID: 33749067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DSP-6952, a novel 5-HT
    Mine Y; Itakura T; Oku S; Asada R; Shimizu I
    Eur J Pharmacol; 2018 May; 826():123-132. PubMed ID: 29428470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological profile of DA-6886, a novel 5-HT4 receptor agonist to accelerate colonic motor activity in mice.
    Lee MJ; Cho KH; Park HM; Sung HJ; Choi S; Im W
    Eur J Pharmacol; 2014 Jul; 735():115-22. PubMed ID: 24769304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraluminal prucalopride increases propulsive motor activities via luminal 5-HT
    Shokrollahi M; Chen JH; Huizinga JD
    Neurogastroenterol Motil; 2019 Oct; 31(10):e13598. PubMed ID: 31012538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial 5-HT
    Mawe GM; Hurd M; Hennig GW; Lavoie B
    Adv Exp Med Biol; 2022; 1383():329-334. PubMed ID: 36587170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of 5-HT3 and 5-HT4 receptors in colonic motor patterns in rats.
    Yu Y; Chen JH; Li H; Yang Z; Du X; Hong L; Liao H; Jiang L; Shi J; Zhao L; Tan S; Luo H; Huizinga JD
    Neurogastroenterol Motil; 2015 Jul; 27(7):914-28. PubMed ID: 25807879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective actions of a luminally acting 5-HT
    Hurd M; Haag MM; Kwasnik MJ; Wykosky J; Lavoie B; Mawe GM
    Neurogastroenterol Motil; 2023 Nov; 35(11):e14673. PubMed ID: 37831752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prucalopride induces high-amplitude propagating contractions in the colon of patients with chronic constipation: a randomized study.
    Miner PB; Camilleri M; Burton D; Achenbach H; Wan H; Dragone J; Mellgard B
    Neurogastroenterol Motil; 2016 Sep; 28(9):1341-8. PubMed ID: 27270968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of prucalopride in adults with chronic idiopathic constipation.
    Vijayvargiya P; Camilleri M
    Expert Rev Clin Pharmacol; 2019 Jul; 12(7):579-589. PubMed ID: 31096799
    [No Abstract]   [Full Text] [Related]  

  • 14. Protective Actions of Epithelial 5-Hydroxytryptamine 4 Receptors in Normal and Inflamed Colon.
    Spohn SN; Bianco F; Scott RB; Keenan CM; Linton AA; O'Neill CH; Bonora E; Dicay M; Lavoie B; Wilcox RL; MacNaughton WK; De Giorgio R; Sharkey KA; Mawe GM
    Gastroenterology; 2016 Nov; 151(5):933-944.e3. PubMed ID: 27480173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects and sites of action of a M1 receptor positive allosteric modulator on colonic motility in rats and dogs compared with 5-HT
    Tsukimi Y; Pustovit RV; Harrington AM; Garcia-Caraballo S; Brierley SM; Di Natale M; Molero JC; Furness JB
    Neurogastroenterol Motil; 2020 Aug; 32(8):e13866. PubMed ID: 32337809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of prucalopride in adults and children with chronic constipation.
    Diederen K; Mugie SM; Benninga MA
    Expert Opin Pharmacother; 2015 Feb; 16(3):407-16. PubMed ID: 25539475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does co-administration of a non-selective opiate antagonist enhance acceleration of transit by a 5-HT4 agonist in constipation-predominant irritable bowel syndrome? A randomized controlled trial.
    Foxx-Orenstein AE; Camilleri M; Szarka LA; McKinzie S; Burton D; Thomforde G; Baxter K; Zinsmeister AR
    Neurogastroenterol Motil; 2007 Oct; 19(10):821-30. PubMed ID: 17539894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Hydroxytryptamine4 receptor agonists and colonic motility.
    Kim HS
    J Smooth Muscle Res; 2009 Feb; 45(1):25-9. PubMed ID: 19377270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice.
    Alemi F; Poole DP; Chiu J; Schoonjans K; Cattaruzza F; Grider JR; Bunnett NW; Corvera CU
    Gastroenterology; 2013 Jan; 144(1):145-54. PubMed ID: 23041323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of 5-HT3 and 5-HT4 receptors in the adaptive mechanism of colonic transit following the parasympathetic denervation in rats.
    Tong W; Kamiyama Y; Ridolfi TJ; Zietlow A; Zheng J; Kosinski L; Ludwig K; Takahashi T
    J Surg Res; 2011 Dec; 171(2):510-6. PubMed ID: 20691988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.